Winderlich Mark 4
4 · HOOKIPA Pharma Inc. · Filed Apr 17, 2024
Insider Transaction Report
Form 4
Winderlich Mark
Chief Development Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-04-15+250,000→ 250,000 totalExercise: $0.76Exp: 2034-04-15→ Common Stock (250,000 underlying) - Award
Stock Option (Right to Buy)
2024-04-15+50,000→ 50,000 totalExercise: $0.76Exp: 2034-04-15→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]25% of this option shall vest on April 15, 2025, with the remainder vesting in 12 equal quarterly installments thereafter.